Anna Kaltenboeck

Ms. Kaltenboeck serves as a senior health advisor to the US Senate Committee on Finance, focusing on drug pricing and outpatient prescription drug coverage under Medicare Part D. Previously, she served as program director and senior health economist at the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center, where she focused on the development and application of value-based pricing methods, as well as sustainable drug-pricing strategies. She has authored and coauthored numerous articles in peer-reviewed journals, including The American Journal of Managed Care, JAMA, Value in Health, and Health Policy. Earlier in her career, Ms. Kaltenboeck held roles with IMS Consulting Group and Analysis Group.

Bio last updated in June 2022.